ANTX: Nilai perusahaan marang bathi resik an2therapeutics.com

Lambang korporat lan logo AN2 Therapeutics (ANTX)

The price action of AN2 Therapeutics, Inc. (ANTX) demonstrates the -4.80 indicator. The business relies on the development of antibiotics in US centers for the therapy of persistent pulmonary pathologies. The environmental development vector includes the minimization of toxic reagents and strict bioethical control. Asset protection is ensured by patents and FDA privileges, although prolonged trials may temporarily reduce the firm's competitive advantages.

Rasio rega marang bathi AN2 Therapeutics (ANTX): kanggo periode 28.04.2023 - 17.11.2026

Rincian metrik komprehensif lan analitis AN2 Therapeutics Inc (ANTX)

- rega lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:ANTX AN2 Bio
Produk sing diprodhuksi AN2 Therapeutics

For the biotechnology sector, where AN2 Therapeutics, Inc. (ANTX) develops antibiotics against resistant infections, this ratio serves as a filter for asset overvaluation prior to the commercialization stage. The ratio of market capitalization to net income, reflected through the current P/E of the business, indicates the cost of one dollar of earnings, allowing for an assessment of potential insurance fund payouts relative to current R&D expenditures.